Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO 2019 Congress

Bristol Myers-Squibb - How immuno-oncology has changed the melanoma treatment landscape

New data for the early treatment of melanoma

Date

27 Sep 2019

Session

Bristol Myers-Squibb - How immuno-oncology has changed the melanoma treatment landscape

Presenters

Eva Muñoz-Couselo

Authors

E. Muñoz-Couselo

Author affiliations

  • Medical Oncology Dept., Vall d'Hebron University Hospital, 08035 - Barcelona/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Eva Muñoz-Couselo

Session: Bristol Myers-Squibb - How immuno-oncology has changed the melanoma treatment landscape

Resources:

Webcast

Summary and close

Presenter: Eva Muñoz-Couselo

Session: Bristol Myers-Squibb - How immuno-oncology has changed the melanoma treatment landscape

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.